Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Gary Ansel

Interventional Cardiology Columbus, OH Medical Doctor

NPI 1932104387 CMS profile 268527

3705 Olentangy River Rd, Suite 100, Columbus, OH 43214

Open in the dashboard

General payments

$3,319,329

626 records reported · program years 2019–2025

Research payments

$31,636

Paid to them · 18 records reported · program years 2019–2025

Ownership & investment interest

$60,533

10 holdings reported · through program year 2025

Research they led as principal investigator

$91,335 paid to institutions, not to them · program years 2019–2021

Through program year 2025, Gary Ansel of Columbus, OH is reported in the CMS Open Payments database as having received $3,319,329 across 626 general payments and $31,636 in research payments paid to them. Separately, studies naming them as principal investigator received $91,335 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $60,533 across 10 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Interventional Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

18 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $558,660 58
2024 General $531,509 110
2023 General $321,764 108
2023 Research $954 1
2022 General $186,379 100
2022 Research $2,800 1
2021 General $164,241 105
2021 Research $700 1
2020 General $510,303 32
2020 Research $27,182 15
2019 General $1,046,472 113
2025 Ownership $10,455 2
2024 Ownership $3,600 1
2023 Ownership $4,180 2
2022 Ownership $1,450 1
2021 Ownership $1,450 1
2020 Ownership $1,700 1
2019 Ownership $37,698 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Gary Ansel
  • Interventional Cardiology median
  • Middle half of Interventional Cardiology
  • National median

In program year 2025, general payments to Gary Ansel were reported at $558,660. Among 6,173 Interventional Cardiology profiles paid that year, the median was $1,092 and the middle half received between $366 and $3,019.

Show as a table
Year Gary Ansel Interventional Cardiology median Middle half National median
2019 $1,046,472 $1,097 $329–$3,048 $163
2020 $510,303 $473 $161–$1,480 $114
2021 $164,241 $677 $233–$1,827 $132
2022 $186,379 $978 $333–$2,724 $149
2023 $321,764 $1,136 $382–$2,986 $160
2024 $531,509 $1,181 $395–$3,326 $164
2025 $558,660 $1,092 $366–$3,019 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Cook Incorporated $2,097,801 30 payments
  2. Surmodics, Inc. $843,226 330 payments
  3. Veryan Medical Incorporated $82,661 15 payments
  4. W. L. Gore & Associates, Inc. $61,780 46 payments
  5. Anika Therapeutics, Inc. $49,998 1 payment
  6. Boston Scientific Corporation $40,030 70 payments
  7. Becton, Dickinson and Company $24,870 2 payments
  8. Medtronic, Inc. $23,673 40 payments
  9. Medtronic Vascular, Inc. $20,409 27 payments
  10. Silk Road Medical, Inc. $15,879 13 payments
  11. Other $59,002 52 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $2,085,424 21 payments
  2. Consulting Fee $1,035,781 126 payments
  3. Travel and Lodging $81,980 235 payments
  4. Current or prospective ownership or investment interest $49,998 1 payment
  5. Honoraria $24,870 2 payments
  6. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $19,700 7 payments
  7. Food and Beverage $18,534 231 payments
  8. Education $1,543 2 payments
  9. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $1,500 1 payment
Products named General payments · program years 2019–2025
  1. Cook Medical Introducers $664,736 4 payments
  2. Performer $419,145 5 payments
  3. Pounce Thrombectomy $364,792 106 payments
  4. Pounce Thrombectomy System Pounce Thrombus Retrieval System $320,918 97 payments
  5. Pounce Venous Thrombectomy System Pounce Venous Thrombectomy System $271,398 100 payments
  6. CHECK-FLO $232,919 3 payments
  7. Cook Medical Catheters $231,863 4 payments
  8. Pounce Venous Thrombectomy System Pounce Venous Thrombectomy System $213,079 64 payments
  9. Pounce Thrombectomy System Percutaneous Catheter System $212,585 57 payments
  10. Pounce Venous Thrombectomy System Venous Thrombectomy System $163,392 53 payments
  11. Other $1,365,620 668 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Philips Electronics North America Corporation $20,013 5 payments
  2. Cook Research Incorporated $5,944 8 payments
  3. InspireMD Ltd $4,454 3 payments
  4. Terumo Medical Corporation $1,225 2 payments

Records

644 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Interventional Cardiology in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record